Company description

Catalyst + Talent

Our name combines these ideas. From drug and biologic development services to delivery technologies to supply solutions, we are the catalyst for your success. With over 75 years of experience, we have the deepest expertise, the broadest offerings, and the most innovative technologies to help you get more molecules to market faster, enhance product performance, and provide superior, reliable manufacturing results.

We serve thousands of innovators, large and small, in over 100 markets, including 36 of the top 50 biotech companies and 49 of the top 50 pharmaceutical companies. Our team of over 1,000 talented scientists supports 40% of recent new drug approvals, and our nearly 30 global sites make or package over 100 billion units annually. Our significant intellectual property in oral, injectable, and respiratory dosage forms and advanced drug packaging includes over 1,200 patents and patent applications.

Quick facts

Sales markets Asia; North America
Primary business activity Distributor; Manufacturer; Service
Affiliated categories: API Contract Manufacturing |Bio Analytical Services |Biotechnology and related specialities More

Upcoming events

5 nov 2019

CPhI Worldwide 2019

5-7 November 2019 Frankfurt, Germany Visit us at stand 121A82 Book a meeting See our Exhibitor Profile   See full Exhibitor List
5 may 2020

CPhI North America 2020

5 - 7 May 2020 Philadelphia, USA Visit us at stand 1301 Book a meeting See our Exhibitor Profile   See full Exhibitor List

Recently at

30 apr 2019

CPhI North America 2019

30 April - 2 May 2019 Chicago, USA We were at stand 1206 See our Exhibitor Profile   See full Exhibitor List
9 oct 2018

CPhI Worldwide 2018

9 - 11 October 2018 Madrid, Spain We were at stand 3D10 See our Exhibitor Profile   See full Exhibitor List
24 apr 2018

CPhI North America 2018

24-26 April, 2018 Philadelphia, USA We were at stand 1401 See our Exhibitor Profile   See full Exhibitor List

News about Catalent

Catalent to purchase BMS manufacturing facility

19 Jun 2019

Catalent to purchase BMS manufacturing facility

Customers to have access to state-of-the-art sterile biologics fill/finish and oral solids manufacturing and packaging platforms.

Read more

14 Apr 2019

Catalent celebrates opening of second Shanghai facility

Catalent’s two Shanghai locations will provide sponsors with an optimized supply solution for studies being undertaken in China, the Asia-Pacific region and globally.

Read more

4 Apr 2019

Catalent expands OptiMelt hot melt extrusion capabilities

The investment includes the addition of equipment to enhance development capabilities for preclinical and early clinical phase development, as well as adding downstream processing technologies to support HME formulations.

Read more

7 Mar 2019

Catalent invests over $27 million to commercialize Zydis Ultra

Zydis Ultra allows a patented and innovative drug coating to be introduced during a product’s formulation, enabling the dosage of active ingredient to be up to four times higher than a conventional Zydis ODT.

Read more